Aster DM Healthcare ₹3 Interim Dividend Record Date is Tomorrow, April 3, 2026

Aster DM Healthcare Limited has announced an interim dividend for the financial year 2025–26. The company’s Board of Directors approved an interim dividend of ₹3 per equity share with a face value of ₹10 each. 

According to the company’s announcement, the dividend will be paid to eligible shareholders within 30 days from the date of declaration. 

Record Date and Ex-Date Details

The company has set Friday, April 3, 2026, as the record date to determine the shareholders eligible to receive the interim dividend. Investors who hold the company’s shares on the record date will qualify for the dividend payout.

The ex-date for this dividend is April 2, 2026. Investors need to purchase the shares before the ex-date to be eligible for the dividend because trades executed on or after the ex-date will not be settled in time to appear in the shareholder records.

Recent Dividend History

Aster DM Healthcare has maintained a consistent dividend distribution over the years. In August 2025, the company declared a final dividend of ₹1 per share. Earlier in February 2025, the company had announced an interim dividend of ₹4 per share.

The company also rewarded shareholders with a final dividend of ₹2 per share in August 2024. One of the most notable payouts in recent years was the special dividend of ₹118 per share announced in April 2024. Such distributions highlight the company’s efforts to return value to its investors through periodic payouts.

Also Read: HDFC Mutual Funds Raises Stake to 2.2% in Aster DM Healthcare!

Conclusion

Dividend announcements like this allow investors to benefit from regular income along with potential capital appreciation. Investors interested in participating in such corporate actions can consider investing in listed companies through the stock market. To begin investing and track dividend-paying stocks, individuals can open a demat account and start building their investment portfolio.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.